Role of p53 and p73 genes polymorphisms in susceptibility to esophageal cancer

A case control study in a northern Indian population

Meenakshi Umar, Rohit Upadhyay, Rohini Khurana, Shaleen Kumar, Uday Chand Ghoshal, Balraj Mittal

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

Genetic variants in p53 and in its homologue p73 may modulate Esophageal Cancer (EC) risk because they are supposed to influence cell cycle progression, apoptosis and DNA repair. Therefore, we aimed to evaluate the association of p53 intron3 16 bp duplication and p73 G4C14-to-A4T14 polymorphisms with susceptibility to EC in a northern Indian population in 255 EC patients and 255 age and sex matched healthy controls. We found that p53 intron3 16 bp duplication polymorphism was not associated with EC and its clinical characteristics. However, p73 G4C14-to-A4T14 polymorphism was associated with significant higher risk of EC (OR = 1.74, 95% CI = 1.16-2.60, P = 0.007) in an allele dose-dependent manner (P trend = 0.0047). Stratification ofsubjects on the basisofclinical characteristics showed that p73 AT genotype carriers were at significant increased risk of developing esophageal squamous cell carcinoma (OR = 1.78, 95% CI = 1.18-2.67, P = 0.006) at middle third tumor location (OR = 1.87, 95% CI = 1.18-2.97, P = 0.007) with lymph node metastasis (OR = 1.77, 95% CI = 1.04-3.02, P = 0.035). No interaction with environmental risk factors was observed with any of the studied polymorphisms. In summary, p73 G4C14-to-A4T14 polymorphism but not the p53 intron3 16 bp duplication polymorphism is associated with EC and its clinical characteristics in northern Indian population.

Original languageEnglish
Pages (from-to)1153-1162
Number of pages10
JournalMolecular Biology Reports
Volume39
Issue number2
DOIs
Publication statusPublished - 1 Feb 2012
Externally publishedYes

Fingerprint

p53 Genes
Esophageal Neoplasms
Case-Control Studies
Population
DNA Repair
Cell Cycle
Lymph Nodes
Alleles
Genotype
Apoptosis
Neoplasm Metastasis
Neoplasms

Keywords

  • Cancer susceptibility
  • Esophageal cancer
  • Genetic polymorphism
  • P53 and p73

ASJC Scopus subject areas

  • Molecular Biology
  • Genetics

Cite this

Role of p53 and p73 genes polymorphisms in susceptibility to esophageal cancer : A case control study in a northern Indian population. / Umar, Meenakshi; Upadhyay, Rohit; Khurana, Rohini; Kumar, Shaleen; Ghoshal, Uday Chand; Mittal, Balraj.

In: Molecular Biology Reports, Vol. 39, No. 2, 01.02.2012, p. 1153-1162.

Research output: Contribution to journalArticle

Umar, Meenakshi ; Upadhyay, Rohit ; Khurana, Rohini ; Kumar, Shaleen ; Ghoshal, Uday Chand ; Mittal, Balraj. / Role of p53 and p73 genes polymorphisms in susceptibility to esophageal cancer : A case control study in a northern Indian population. In: Molecular Biology Reports. 2012 ; Vol. 39, No. 2. pp. 1153-1162.
@article{ee35bdb16bd941bb9163cc4914706554,
title = "Role of p53 and p73 genes polymorphisms in susceptibility to esophageal cancer: A case control study in a northern Indian population",
abstract = "Genetic variants in p53 and in its homologue p73 may modulate Esophageal Cancer (EC) risk because they are supposed to influence cell cycle progression, apoptosis and DNA repair. Therefore, we aimed to evaluate the association of p53 intron3 16 bp duplication and p73 G4C14-to-A4T14 polymorphisms with susceptibility to EC in a northern Indian population in 255 EC patients and 255 age and sex matched healthy controls. We found that p53 intron3 16 bp duplication polymorphism was not associated with EC and its clinical characteristics. However, p73 G4C14-to-A4T14 polymorphism was associated with significant higher risk of EC (OR = 1.74, 95{\%} CI = 1.16-2.60, P = 0.007) in an allele dose-dependent manner (P trend = 0.0047). Stratification ofsubjects on the basisofclinical characteristics showed that p73 AT genotype carriers were at significant increased risk of developing esophageal squamous cell carcinoma (OR = 1.78, 95{\%} CI = 1.18-2.67, P = 0.006) at middle third tumor location (OR = 1.87, 95{\%} CI = 1.18-2.97, P = 0.007) with lymph node metastasis (OR = 1.77, 95{\%} CI = 1.04-3.02, P = 0.035). No interaction with environmental risk factors was observed with any of the studied polymorphisms. In summary, p73 G4C14-to-A4T14 polymorphism but not the p53 intron3 16 bp duplication polymorphism is associated with EC and its clinical characteristics in northern Indian population.",
keywords = "Cancer susceptibility, Esophageal cancer, Genetic polymorphism, P53 and p73",
author = "Meenakshi Umar and Rohit Upadhyay and Rohini Khurana and Shaleen Kumar and Ghoshal, {Uday Chand} and Balraj Mittal",
year = "2012",
month = "2",
day = "1",
doi = "10.1007/s11033-011-0844-9",
language = "English",
volume = "39",
pages = "1153--1162",
journal = "Molecular Biology Reports",
issn = "0301-4851",
publisher = "Springer Netherlands",
number = "2",

}

TY - JOUR

T1 - Role of p53 and p73 genes polymorphisms in susceptibility to esophageal cancer

T2 - A case control study in a northern Indian population

AU - Umar, Meenakshi

AU - Upadhyay, Rohit

AU - Khurana, Rohini

AU - Kumar, Shaleen

AU - Ghoshal, Uday Chand

AU - Mittal, Balraj

PY - 2012/2/1

Y1 - 2012/2/1

N2 - Genetic variants in p53 and in its homologue p73 may modulate Esophageal Cancer (EC) risk because they are supposed to influence cell cycle progression, apoptosis and DNA repair. Therefore, we aimed to evaluate the association of p53 intron3 16 bp duplication and p73 G4C14-to-A4T14 polymorphisms with susceptibility to EC in a northern Indian population in 255 EC patients and 255 age and sex matched healthy controls. We found that p53 intron3 16 bp duplication polymorphism was not associated with EC and its clinical characteristics. However, p73 G4C14-to-A4T14 polymorphism was associated with significant higher risk of EC (OR = 1.74, 95% CI = 1.16-2.60, P = 0.007) in an allele dose-dependent manner (P trend = 0.0047). Stratification ofsubjects on the basisofclinical characteristics showed that p73 AT genotype carriers were at significant increased risk of developing esophageal squamous cell carcinoma (OR = 1.78, 95% CI = 1.18-2.67, P = 0.006) at middle third tumor location (OR = 1.87, 95% CI = 1.18-2.97, P = 0.007) with lymph node metastasis (OR = 1.77, 95% CI = 1.04-3.02, P = 0.035). No interaction with environmental risk factors was observed with any of the studied polymorphisms. In summary, p73 G4C14-to-A4T14 polymorphism but not the p53 intron3 16 bp duplication polymorphism is associated with EC and its clinical characteristics in northern Indian population.

AB - Genetic variants in p53 and in its homologue p73 may modulate Esophageal Cancer (EC) risk because they are supposed to influence cell cycle progression, apoptosis and DNA repair. Therefore, we aimed to evaluate the association of p53 intron3 16 bp duplication and p73 G4C14-to-A4T14 polymorphisms with susceptibility to EC in a northern Indian population in 255 EC patients and 255 age and sex matched healthy controls. We found that p53 intron3 16 bp duplication polymorphism was not associated with EC and its clinical characteristics. However, p73 G4C14-to-A4T14 polymorphism was associated with significant higher risk of EC (OR = 1.74, 95% CI = 1.16-2.60, P = 0.007) in an allele dose-dependent manner (P trend = 0.0047). Stratification ofsubjects on the basisofclinical characteristics showed that p73 AT genotype carriers were at significant increased risk of developing esophageal squamous cell carcinoma (OR = 1.78, 95% CI = 1.18-2.67, P = 0.006) at middle third tumor location (OR = 1.87, 95% CI = 1.18-2.97, P = 0.007) with lymph node metastasis (OR = 1.77, 95% CI = 1.04-3.02, P = 0.035). No interaction with environmental risk factors was observed with any of the studied polymorphisms. In summary, p73 G4C14-to-A4T14 polymorphism but not the p53 intron3 16 bp duplication polymorphism is associated with EC and its clinical characteristics in northern Indian population.

KW - Cancer susceptibility

KW - Esophageal cancer

KW - Genetic polymorphism

KW - P53 and p73

UR - http://www.scopus.com/inward/record.url?scp=84860338714&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84860338714&partnerID=8YFLogxK

U2 - 10.1007/s11033-011-0844-9

DO - 10.1007/s11033-011-0844-9

M3 - Article

VL - 39

SP - 1153

EP - 1162

JO - Molecular Biology Reports

JF - Molecular Biology Reports

SN - 0301-4851

IS - 2

ER -